“…Nevertheless, potential sex differences in the processing of MMP‐9 (Griffiths, Madden, Edwards, Zup, & Stary, 2019) together with evidence that females may metabolize fluoxetine faster than males, hence maybe more susceptive to alterations in dosage and to withdrawal (Hodes, Hill‐Smith, Suckow, Cooper, & Lucki, 2010), calls for more basic research on the subject. Specifically, since interplay of oestrogen and its receptors in various tissues with MMP‐9 (Ahmad, Chen, Wang, & Kapila, 2018; Chen & Khalil, 2017; Foresta et al, 2010; Hu et al, 2006; Lewandowski et al, 2006; Lobo, 2008; Pan et al, 2020; Wolak & Hrabia, 2020; Zhao et al, 2019) and perineuronal nets (Batista & Hensch, 2019; Lin et al, 2018; Uriarte, Ferreño, Méndez, & Nogueira, 2020) was previously reported, studying the potential role of the oestrous cycle in the molecular mechanisms related to longitudinal fluoxetine intake seems especially interesting avenue of research. However, in our findings longitudinal design of the testing protocols, including 5‐day‐long assessment of reward learning, excludes the possibility that observed effects are attributable to a specific hormonal phase, such studies might put the present results in a new context.…”